Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2025-12-27 @ 8:13 AM
Study NCT ID:
NCT01367132
Status:
COMPLETED
Last Update Posted:
2013-02-22
First Post:
2011-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of the Number of Umbilical Cord Vessels at the Time of Nuchal Translucency Screening
Sponsor:
Medstar Health Research Institute
Organization:
Study Overview
Official Title:
Assessment of the Number of Umbilical Cord Vessels at the Time of Nuchal Translucency Screening
Status:
COMPLETED
Status Verified Date:
2013-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study is to determine the detection rate of two- or three-vessel umbilical cord at the time of nuchal translucency screening between 11 and 13 6/7 weeks gestation.
Hypothesis: Detection rate of the number of vessels during first trimester will be as accurate as the detection of vessels during the second trimester.
Hypothesis: Detection rate of the number of vessels during first trimester will be as accurate as the detection of vessels during the second trimester.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: